Central Nervous System Pharmacology Practice Questions

Q: A patient presents with severe headaches and is diagnosed with a migraine. Which drug, acting as a serotonin 1D agonist, is used to abort the migraine attack?

Serotonin 1D agonist. ***Serotonin 1D agonist*** - **Triptans**, a class of drugs acting as **5-HT1D/1B receptor agonists**, are the most specific and effective agents for aborting acute migraine attacks. - They work by causing **vasoconstriction of intracranial blood vessels** and inhibiting the release of **pro-inflammatory neuropeptides**. *Dopamine 1 agonist* - **Dopamine agonists** are generally used in conditions like **Parkinson's disease** to improve motor symptoms. - They are not indicated for the acute treatment of migraine as they do not target the specific pathways involved in migraine pathophysiology. *GABAB antagonist* - **GABA-B antagonists** are not used to abort migraine attacks; in fact, **GABA-B agonists** can sometimes be used to manage certain neurological conditions. - These drugs mainly modulate neuronal excitability and have no direct role in the acute vasoconstriction or pain pathways of migraine. *Non-selective beta antagonist* - **Non-selective beta-blockers** (e.g., propranolol) are primarily used for **migraine prophylaxis** (prevention), not for aborting an acute attack. - They work by reducing neuronal excitability and preventing the cascade of events that lead to a migraine, but they do not provide rapid relief during an attack.

Q: A 60-year-old man with Alzheimer's disease has been started on donepezil. What is the primary mechanism of action of this medication?

Acetylcholinesterase inhibitor. ***Acetylcholinesterase inhibitor*** - Donepezil **blocks the enzyme acetylcholinesterase**, which is responsible for breaking down acetylcholine [1], [2]. - By inhibiting this enzyme, donepezil **increases the levels of acetylcholine** in the brain, improving **cholinergic neurotransmission** in patients with Alzheimer's disease [2]. *NMDA receptor antagonist* - **NMDA receptor antagonists** like **memantine** work by blocking the activity of glutamate at the NMDA receptor, which is thought to reduce excitotoxicity in Alzheimer's [1], [3]. - This mechanism is different from donepezil, which targets the **cholinergic system** [1]. *Dopamine receptor antagonist* - **Dopamine receptor antagonists** are primarily used in conditions like **schizophrenia** or **Parkinson's disease** (for psychotic symptoms), by blocking dopamine receptors. - This is not the mechanism of action for medications used to treat cognitive symptoms of Alzheimer's disease. *Serotonin reuptake inhibitor* - **Serotonin reuptake inhibitors (SSRIs)** are a class of antidepressants that increase serotonin levels in the brain by blocking its reuptake [3]. - While depression can co-occur with Alzheimer's, SSRIs do not directly address the cognitive decline associated with the disease [3].

Q: What is the drug of choice for juvenile myoclonic epilepsy?

Valproic acid. ***Valproic acid*** - **Valproic acid** is considered the first-line and most effective treatment for **juvenile myoclonic epilepsy (JME)**, effectively controlling myoclonic, generalized tonic-clonic, and absence seizures common in this syndrome. [1] - It works by increasing **GABA activity**, blocking voltage-gated sodium channels, and inhibiting T-type calcium channels, all of which contribute to its broad-spectrum anticonvulsant effects. *Oxcarbazepine* - **Oxcarbazepine** is a sodium channel blocker primarily used for **focal (partial) seizures** and is generally not effective for generalized epilepsies like JME. - It can sometimes worsen myoclonic seizures or generalized tonic-clonic seizures in patients with JME. *Zonisamide* - **Zonisamide** is a broad-spectrum antiepileptic drug that can be used for various seizure types, including generalized seizures, but it is typically a **second-line agent** or an add-on therapy for JME, not the first-line drug of choice. - Its mechanism involves blocking sodium and T-type calcium channels, but its efficacy in JME is generally considered less robust than valproic acid. *Lacosamide* - **Lacosamide** selectively enhances slow inactivation of voltage-gated sodium channels and is approved primarily for the treatment of **focal-onset seizures**. [2] - It is **not recommended** for juvenile myoclonic epilepsy because it can exacerbate myoclonic seizures and generalized tonic-clonic seizures and has no proven efficacy in this epilepsy syndrome.

Q: Which of the following non-depolarizing neuromuscular blockers does not cause the release of histamine?

Vecuronium. ***Vecuronium*** - **Vecuronium** is an aminosteroid non-depolarizing neuromuscular blocker known for its minimal cardiovascular effects and **lack of histamine release**. - Its chemical structure (lacking quaternary ammonium groups in certain positions) contributes to its **low propensity for histamine release**, making it suitable for patients with reactive airway disease or cardiovascular instability. *d-tubocurarine* - **d-tubocurarine** is a classic non-depolarizing neuromuscular blocker that is well-known for causing significant **histamine release**, leading to **hypotension** and **bronchospasm**. - Due to its side effect profile, it is rarely used in modern clinical practice. *Atracurium* - **Atracurium** is a benzylisoquinolinium non-depolarizing neuromuscular blocker that can cause **histamine release**, particularly with rapid administration or higher doses. - While its histamine-releasing properties are less pronounced than d-tubocurarine, they can still lead to **cutaneous flushing** and **hypotension**. *Mivacurium* - **Mivacurium** is another benzylisoquinolinium non-depolarizing neuromuscular blocker that is known to cause **histamine release**, especially at higher doses or rapid injection rates. - The histamine release from mivacurium is generally dose-dependent and can result in **flushing** and **transient hypotension**.

Q: A 30-year-old man presents with multiple small red papules on his face and chest that appeared after starting a new medication. Which medication is most likely the cause?

Phenytoin. ***Phenytoin*** - **Phenytoin** is well-known for causing **drug-induced hypersensitivity reactions** presenting as **morbilliform (measles-like) or exanthematous eruptions** with small, red papules - These reactions typically appear within **1-3 weeks** of starting therapy and commonly affect the **face, trunk, and upper extremities** - Phenytoin can also cause more severe reactions like **DRESS syndrome** and **SJS/TEN**, making recognition of early cutaneous signs clinically important - In the context of pharmacology testing, phenytoin's dermatological side effects are **high-yield** and frequently examined *Amoxicillin* - While **amoxicillin** is a common cause of drug rashes overall (affecting 5-10% of patients), these rashes are often **delayed** (appearing 4-14 days after treatment) and frequently **non-allergic** in nature - The classic "**amoxicillin rash**" often occurs in the context of **viral infections** (especially EBV) rather than as a true drug hypersensitivity - Without additional context suggesting concurrent viral illness, other medications should be considered first *Hydrochlorothiazide* - **Hydrochlorothiazide** primarily causes **photosensitivity reactions** that require sun exposure, presenting as sunburn-like eruptions in sun-exposed areas - Can also rarely cause **lichenoid eruptions** or **vasculitis**, but generalized small red papules are not its characteristic presentation *Prednisone* - **Prednisone** is a corticosteroid with **anti-inflammatory and immunosuppressive** properties that typically **suppress rash formation** - Chronic use may cause **steroid acne** or skin atrophy, but acute papular eruptions after starting the medication are highly unlikely - Prednisone is often used to **treat** drug-induced rashes, not cause them

Q: A patient on donepezil for Alzheimer's disease begins to experience bradycardia. What is the likely mechanism of this side effect?

Inhibition of acetylcholinesterase. ***Inhibition of acetylcholinesterase*** - Donepezil is an **acetylcholinesterase inhibitor**, meaning it increases the amount of **acetylcholine** in the synaptic cleft. - Increased acetylcholine activity at muscarinic receptors in the heart, particularly **M2 receptors**, leads to **bradycardia** by decreasing the heart rate and conduction velocity. *Increased GABAergic transmission* - **GABA** (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the central nervous system and primarily affects neuronal excitability, not directly cardiac rhythm. - Medications that increase GABAergic transmission typically cause **sedation** or **anxiolysis**, and are not directly associated with bradycardia as a primary mechanism. *Blockade of NMDA receptors* - **NMDA receptor blockers** (e.g., memantine) are used in Alzheimer's disease to modulate glutamate activity, but they do not directly influence the cholinergic system or heart rate in a way that causes bradycardia. - Their primary effects are on neuronal excitability and neuroprotection, rather than autonomic cardiac function. *Increased dopamine release* - **Dopamine** acts on alpha, beta, and dopaminergic receptors; its release generally tends to **increase heart rate** and cardiac contractility rather than cause bradycardia. - Increased dopamine is not a mechanism of action for donepezil, which specifically targets acetylcholine.

Q: Which of the following antiepileptic drugs is preferred for treating generalized tonic-clonic seizures?

Valproic acid. ***Valproic acid*** - **Valproic acid** is a broad-spectrum antiepileptic drug effective against various seizure types, including **generalized tonic-clonic seizures**. - It is considered the **gold standard** for generalized seizures because it is effective against all types (absence, myoclonic, and tonic-clonic). - It works by increasing GABA levels, blocking voltage-gated sodium channels, and inhibiting T-type calcium channels. *Ethosuximide* - **Ethosuximide** is specifically used for **absence seizures** (petit mal) and is not effective for generalized tonic-clonic seizures. - It primarily acts by blocking **T-type calcium channels** in the thalamus. *Gabapentin* - **Gabapentin** is primarily used for **focal (partial) seizures** and neuropathic pain, not generalized tonic-clonic seizures. - Its mechanism involves modulating the release of neurotransmitters, possibly by binding to the **α2δ subunit of calcium channels**. *Carbamazepine* - **Carbamazepine** is a first-line treatment for **focal (partial) seizures** and is also effective for **generalized tonic-clonic seizures**, though valproic acid is generally preferred for purely generalized seizures. - It works by blocking voltage-gated sodium channels. - It should be **avoided in absence and myoclonic seizures** as it can worsen these seizure types. - Also used for **trigeminal neuralgia**.

Q: What is the benefit of combining levodopa with carbidopa in the treatment of Parkinson's disease?

Reduces peripheral side effects of levodopa. ***Reduces peripheral side effects of levodopa*** - Carbidopa is a **dopa decarboxylase inhibitor** that does not cross the blood-brain barrier. It inhibits the peripheral conversion of levodopa to dopamine, thereby reducing peripheral side effects like **nausea**, **vomiting**, and **cardiac arrhythmias**. - By reducing peripheral metabolism, more levodopa is available to cross the **blood-brain barrier** and be converted to dopamine in the brain, improving therapeutic efficacy. *Enhances CNS penetration of levodopa* - Carbidopa itself **does not cross the blood-brain barrier**, so it cannot directly enhance the central nervous system (CNS) penetration of levodopa. - Its action is primarily in the **periphery**, preventing levodopa's premature conversion to dopamine before it reaches the brain. *Prolongs the half-life of levodopa* - While carbidopa increases the amount of levodopa available to the brain, it does not significantly **prolong the plasma half-life** of levodopa itself. - The primary effect is to **reduce peripheral metabolism**, allowing a greater proportion of the administered dose to reach the CNS. *Increases dopamine receptor sensitivity* - Carbidopa's mechanism of action involves **enzyme inhibition** (dopa decarboxylase) and does not directly affect the sensitivity of **dopamine receptors** in the brain. - Levodopa is converted to dopamine, which then acts on these receptors, but carbidopa does not modulate their sensitivity.

Q: Which antiepileptic drug is most strongly contraindicated in pregnancy due to its teratogenic effects?

Valproic acid. ***Valproic acid*** - Valproic acid is strongly **teratogenic**, associated with a high risk of **neural tube defects** (e.g., spina bifida), as well as developmental delays and cardiac abnormalities. - Due to these severe risks, it is generally **contraindicated during pregnancy**, especially in the first trimester, unless no other safer alternative is effective for severe epilepsy. *Carbamazepine* - While carbamazepine *does* have teratogenic potential, particularly increasing the risk of **neural tube defects**, its risk is generally considered lower than that of valproic acid. - It is often managed with **folic acid supplementation** if used in pregnancy, and it is not universally contraindicated, though careful consideration is necessary. *Levetiracetam* - Levetiracetam is generally considered one of the **safer antiepileptic drugs** for use during pregnancy, with relatively low rates of major congenital malformations. - It is often a preferred choice for managing epilepsy in pregnant women, weighing the risks and benefits. *Gabapentin* - Gabapentin is also generally considered to have a **lower teratogenic risk** compared to older antiepileptics like valproic acid. - While not entirely without risk, it is often favored when alternative monotherapies are not suitable or tolerated.

Question 1

A patient presents with severe headaches and is diagnosed with a migraine. Which drug, acting as a serotonin 1D agonist, is used to abort the migraine attack?

Accepted Answer

Serotonin 1D agonist

Answer

Dopamine 1 agonist

Answer

GABAB antagonist

Answer

Non-selective beta antagonist

Question 2

A 60-year-old man with Alzheimer's disease has been started on donepezil. What is the primary mechanism of action of this medication?

Accepted Answer

Acetylcholinesterase inhibitor

Answer

NMDA receptor antagonist

Answer

Dopamine receptor antagonist

Answer

Serotonin reuptake inhibitor

Question 3

What are the roles of cholinesterase inhibitors and NMDA receptor antagonists in the treatment of Alzheimer's disease?

Accepted Answer

Cholinesterase inhibitors enhance cognitive function; NMDA antagonists reduce excitotoxicity

Answer

Cholinesterase inhibitors reduce excitotoxicity; NMDA antagonists enhance cognitive function

Answer

Both target glutamate neurotransmission

Answer

Both improve memory by increasing acetylcholine

Question 4

What is the drug of choice for juvenile myoclonic epilepsy?

Accepted Answer

Valproic acid

Answer

Oxcarbazepine

Answer

Zonisamide

Answer

Lacosamide

Question 5

Which of the following non-depolarizing neuromuscular blockers does not cause the release of histamine?

Accepted Answer

Vecuronium

Answer

d-tubocurarine

Answer

Mivacurium

Answer

Atracurium

Question 6

A 30-year-old man presents with multiple small red papules on his face and chest that appeared after starting a new medication. Which medication is most likely the cause?

Accepted Answer

Phenytoin

Answer

Amoxicillin

Answer

Hydrochlorothiazide

Answer

Prednisone

Question 7

A patient on donepezil for Alzheimer's disease begins to experience bradycardia. What is the likely mechanism of this side effect?

Accepted Answer

Inhibition of acetylcholinesterase

Answer

Increased GABAergic transmission

Answer

Blockade of NMDA receptors

Answer

Increased dopamine release

Question 8

Which of the following antiepileptic drugs is preferred for treating generalized tonic-clonic seizures?

Accepted Answer

Valproic acid

Answer

Ethosuximide

Answer

Gabapentin

Answer

Carbamazepine

Question 9

What is the benefit of combining levodopa with carbidopa in the treatment of Parkinson's disease?

Accepted Answer

Reduces peripheral side effects of levodopa

Answer

Enhances CNS penetration of levodopa

Answer

Prolongs the half-life of levodopa

Answer

Increases dopamine receptor sensitivity

Question 10

Which antiepileptic drug is most strongly contraindicated in pregnancy due to its teratogenic effects?

Accepted Answer

Valproic acid

Answer

Carbamazepine

Answer

Levetiracetam

Answer

Gabapentin

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?